Anti-CD22 [LL2 (EPB2)]
Ab01486-2.3
ApplicationsFlow Cytometry, ImmunoHistoChemistry, RadioImmunoAssay
Product group Antibodies
ReactivityHuman
TargetCD22
Overview
- SupplierAbsolute Antibody
- Product NameAnti-CD22 [LL2 (EPB2)]
- Delivery Days Customer7
- Antibody SpecificityThis antibody recognises CD22, which is a cytoplasmic molecule expressed in progenitor and early-pre B cells.
- Application Supplier NoteThis antibody has been used in research on the diagnosis and treatment of non-Hodgkins B cell lymphoma. Specificity to B-cell line of the LL2 (EPB-2) antibody was confirmed by radioimmunobinding and flow cytometry, where it did not bind to any other targets, such as T cells and normal diploid cells at the same time labelling malignant lymphoma tissue (Pawlak-Byczkowska et al., 1989).
- ApplicationsFlow Cytometry, ImmunoHistoChemistry, RadioImmunoAssay
- Applications SupplierRIA; FC; IHC
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone IDLL2 (EPB2)
- Gene ID933
- Target nameCD22
- Target descriptionCD22 molecule
- Target synonymsB-cell receptor CD22; BL-CAM; B-lymphocyte cell adhesion molecule; CD22 antigen; sialic acid-binding Ig-like lectin 2; SIGLEC2; SIGLEC-2; T-cell surface antigen Leu-14
- HostMouse
- IsotypeIgG2a
- Protein IDP20273
- Protein NameB-cell receptor CD22
- ReactivityHuman
- Reactivity SupplierHuman
- Reactivity Supplier NoteThis antibody was raised by immunising Balb/c mice with Raji cells or a fragmented cell mixture.
- Storage Instruction-20°C,2°C to 8°C
- UNSPSC12352203